Raf kinase inhibitor protein (RKIP) in cancer

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 615-620

  Escara Wilke, June ^a   Yeung, Kam ^b   Keller, Evan T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Chemoresistance; Metastasis; Prostate cancer; Radioresistance; RKIP

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CISPLATIN; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROSTATE SPECIFIC ANTIGEN; RAF PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

AMINO ACID ANALYSIS; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CHROMOSOME 2P; COLON CANCER; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME SUBSTRATE; HUMAN; IN VITRO STUDY; INHIBITION KINETICS; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TARGETING; RADIOSENSITIVITY; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NF-E2-RELATED FACTOR 2; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; STAT3 TRANSCRIPTION FACTOR;

EID: 84867999452     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9365-9     Document Type: Article

References (51)

1. Bernier, I.; & Jolles, P. (1984). Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochimica et Biophysica Acta, 790(2), 174-181.
2. Perry, A. C.; Hall, L.; Bell, A. E.; & Jones, R. (1994). Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochemical Journal, 301(Pt 1), 235-242.
3. Grandy, D. K.; Hanneman, E.; Bunzow, J.; Shih, M.; Machida, C. A.; Bidlack, J. M.; et al. (1990). Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Molecular Endocrinology, 4(9), 1370-1376.
4. Bollengier, F.; & Mahler, A. (1988). Localization of the novel neuropolypeptide h3 in subsets of tissues from different species. Journal of Neurochemistry, 50(4), 1210-1214.
5. Hori, N.; Chae, K. S.; Murakawa, K.; Matoba, R.; Fukushima, A.; Okubo, K.; et al. (1994). A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein. Gene, 140(2), 293-294.
6. Seddiqi, N.; Bollengier, F.; Alliel, P. M.; Perin, J. P.; Bonnet, F.; Bucquoy, S.; et al. (1994). Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. Journal of Molecular Evolution, 39(6), 655-660.
7. Banfield, M. J.; Barker, J. J.; Perry, A. C.; & Brady, R. L. (1998). Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure, 6(10), 1245-1254.
8. Fu, Z.; Smith, P. C.; Zhang, L.; Rubin, M. A.; Dunn, R. L.; Yao, Z.; et al. (2003). Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal of the National Cancer Institute, 95(12), 878-889.
9. Simister, P. C.; Banfield, M. J.; & Brady, R. L. (2002). The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallographica Section D: Biological Crystallography, 58(Pt 6 Pt 2), 1077-1080.
10. Park, S.; Yeung, M. L.; Beach, S.; Shields, J. M.; & Yeung, K. C. (2005). RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene, 24, 3535-3540.
11. Yeung, K.; Seitz, T.; Li, S.; Janosch, P.; McFerran, B.; Kaiser, C.; et al. (1999). Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature, 401(6749), 173-177. doi: 10.1038/43686.
12. Yeung, K. C.; Rose, D. W.; Dhillon, A. S.; Yaros, D.; Gustafsson, M.; Chatterjee, D.; et al. (2001). Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Molecular and Cellular Biology, 21(21), 7207-7217.
13. Park, S.; Rath, O.; Beach, S.; Xiang, X.; Kelly, S. M.; Luo, Z.; et al. (2006). Regulation of RKIP binding to the N-region of the Raf-1 kinase. FEBS Letters, 580(27), 6405-6412.
14. Rath, O.; Park, S.; Tang, H. H.; Banfield, M. J.; Brady, R. L.; Lee, Y. C.; et al. (2008). The RKIP (Raf-1 kinase inhibitor protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. Cellular Signalling, 20(5), 935-941.
15. Yeung, K.; Janosch, P.; McFerran, B.; Rose, D. W.; Mischak, H.; Sedivy, J. M.; et al. (2000). Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein. Molecular and Cellular Biology, 20(9), 3079-3085.
16. Al-Mulla, F.; Bitar, M. S.; Al-Maghrebi, M.; Behbehani, A. I.; Al-Ali, W.; Rath, O.; et al. (2011). Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3beta. Cancer Research, 71(4), 1334-1343.
17. Al-Mulla, F.; Bitar, M. S.; Feng, J.; Park, S.; & Yeung, K. C. (2012). A new model for Raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One, 7(1), e29532. doi: 10.1371/journal.pone.0029532.
18. Chatterjee, D.; Sabo, E.; Tavares, R.; & Resnick, M. B. (2008). Inverse association between Raf kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome. Clinical Cancer Research, 14(10), 2994-3001.
19. Lorenz, K.; Lohse, M. J.; & Quitterer, U. (2003). Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature, 426(6966), 574-579.
20. Tang, H.; Park, S.; Sun, S. C.; Trumbly, R.; Ren, G.; Tsung, E.; et al. (2010). RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Letters, 584(4), 662-668.
21. Corbit, K. C.; Trakul, N.; Eves, E. M.; Diaz, B.; Marshall, M.; & Rosner, M. R. (2003). Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. Journal of Biological Chemistry, 278(15), 13061-13068.
22. Germain, D.; & Frank, D. A. (2007). Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clinical Cancer Research, 13(19), 5665-5669.
23. Al-Mulla, F.; Hagan, S.; Behbehani, A. I.; Bitar, M. S.; George, S. S.; Going, J. J.; et al. (2006). Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. Journal of Clinical Oncology, 24(36), 5672-5679.
24. Chatterjee, D.; Bai, Y.; Wang, Z.; Beach, S.; Mott, S.; Roy, R.; et al. (2004). RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. Journal of Biological Chemistry, 279(17), 17515-17523.
25. Hagan, S.; Al-Mulla, F.; Mallon, E.; Oien, K. A.; Ferrier, R.; Gusterson, B.; et al. (2005). Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastases. Clinical Cancer Research 11:7392-7397.
26. Lee, H. C.; Tian, B.; Sedivy, J. M.; Wands, J. R.; & Kim, M. (2006). Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology, 131(4), 1208-1217.
27. Schuierer, M. M.; Bataille, F.; Hagan, S.; Kolch, W.; & Bosserhoff, A. K. (2004). Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Research, 64(15), 5186-5192.
28. Schuierer, M. M.; Bataille, F.; Weiss, T. S.; Hellerbrand, C.; & Bosserhoff, A. K. (2006). Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncology Reports, 16(3), 451-456.
29. Zhang, L.; Fu, Z.; Binkley, C.; Giordano, T.; Burant, C. F.; Logsdon, C. D.; et al. (2004). Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery, 136(3), 708-715.
30. Lopez, M.; Maroc, N.; Kerangueven, F.; Bardin, F.; Courcoul, M.; Lavezzi, C.; et al. (1991). Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Experimental Hematology, 19, 797-803.
31. Martinho, O.; Faloppa, C. C.; Neto, C. S.; Longatto-Filho, A.; Baiocchi, G.; da Cunha, I. W.; et al. (2012). Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. Journal of Clinical Pathology, 65(2), 122-128. doi: 10.1136/jclinpath-2011-200358.
32. Jia, B.; Liu, H.; Kong, Q.; & Li, B. (2012). RKIP expression associated with gastric cancer cell invasion and metastasis. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. doi: 10.1007/s13277-012-0317-3.
33. Zaravinos, A.; Chatziioannou, M.; Lambrou, G. I.; Boulalas, I.; Delakas, D.; & Spandidos, D. A. (2011). Implication of RAF and RKIP genes in urinary bladder cancer. Pathology Oncology Research: POR, 17(2), 181-190. doi: 10.1007/s12253-010-9295-1.
34. Fu, Z.; Kitagawa, Y.; Shen, R.; Shah, R.; Mehra, R.; Rhodes, D.; et al. (2006). Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate, 66(3), 248-256. doi: 10.1002/pros.20319.
35. Beshir, A. B.; Ren, G.; Magpusao, A. N.; Barone, L. M.; Yeung, K. C.; & Fenteany, G. (2010). Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Letters, 299(2), 137-149.
36. Dangi-Garimella, S.; Yun, J.; Eves, E. M.; Newman, M.; Erkeland, S. J.; Hammond, S. M.; et al. (2009). Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO Journal, 28(4), 347-358.
37. Martinho, O.; Granja, S.; Jaraquemada, T.; Caeiro, C.; Miranda-Goncalves, V.; Honavar, M.; et al. (2012). Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One, 7(1), e30769. doi: 10.1371/journal.pone.0030769.
38. Yun, J.; Frankenberger, C. A.; Kuo, W. L.; Boelens, M. C.; Eves, E. M.; Cheng, N.; et al. (2011). Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO Journal, 30(21), 4500-4514.
39. Sears, R.; Leone, G.; DeGregori, J.; & Nevins, J. R. (1999). Ras enhances Myc protein stability. Molecular Cell, 3(2), 169-179.
40. Xinzhou, H.; Ning, Y.; Ou, W.; Xiaodan, L.; Fumin, Y.; Huitu, L.; et al. (2011). RKIp inhibits the migration and invasion of human prostate cancer PC-3 M cells through regulation of extracellular matrix [Research Support, non-U.S.-Gov't]. Molekuliarnaia Biologiia, 45(6), 1004-1011.
41. Baritaki, S.; & Bonavida, B. (2010). Viral infection and cancer: The NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Critical Reviews in Immunology, 30(1), 31-46.
42. Baritaki, S.; Katsman, A.; Chatterjee, D.; Yeung, K. C.; Spandidos, D. A.; & Bonavida, B. (2007). Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. Journal of Immunology, 179, 5441-5453.
43. Baritaki, S.; Yeung, K.; Palladino, M.; Berenson, J.; & Bonavida, B. (2009). Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Cancer Research, 69(21), 8376-8385.
44. Woods Ignatoski, K. M.; Grewal, N. K.; Markwart, S. M.; Vellaichamy, A.; Chinnaiyan, A. M.; Yeung, K.; et al. (2008). Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. International Journal of Radiation Oncology, Biology, and Physics, 72(1), 153-160.
45. Kobayashi, A.; Ohta, T.; & Yamamoto, M. (2004). Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods in Enzymology, 378, 273-286. doi: 10.1016/S0076-6879(04)78021-0.
46. Lee, J. M.; Calkins, M. J.; Chan, K.; Kan, Y. W.; & Johnson, J. A. (2003). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. Journal of Biological Chemistry, 278(14), 12029-12038. doi: 10.1074/jbc.M211558200.
47. Venugopal, R.; & Jaiswal, A. K. (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proceedings of the National Academy of Sciences of the United States of America, 93(25), 14960-14965.
48. Thimmulappa, R. K.; Mai, K. H.; Srisuma, S.; Kensler, T. W.; Yamamoto, M.; & Biswal, S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research, 62(18), 5196-5203.
49. Hu, C. J.; Zhou, L.; Zhang, J.; Huang, C.; & Zhang, G. M. (2011). Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. The Journal of International Medical Research, 39(1), 229-237.
50. Huerta-Yepez, S.; Yoon, N. K.; Hernandez-Cueto, A.; Mah, V.; Rivera-Pazos, C. M.; Chatterjee, D.; et al. (2011). Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer, 11, 259. doi: 10.1186/1471-2407-11-259.
51. Ruan, L.; Wang, G. L.; Yi, H.; Chen, Y.; Tang, C. E.; Zhang, P. F.; et al. (2010). Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. [Research Support, non-U.S.-Gov't]. Journal of Cellular Biochemistry, 110(4), 975-981. doi: 10.1002/jcb.22611.